CORC

浏览/检索结果: 共91条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Shi, Yuankai;  Zhang, Qing Yuan;  Hong, Xiaonan;  Wang, Zhen;  Gao, Yuhuan
收藏  |  浏览/下载:14/0  |  提交时间:2022/12/23
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong
收藏  |  浏览/下载:38/0  |  提交时间:2020/12/24
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 5
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/05
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis 期刊论文
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 卷号: 4, 页码: 389-398
作者:  Li, Jie;  Zou, Biyao;  Yeo, Yee Hui;  Feng, Yuemin;  Xie, Xiaoyu
收藏  |  浏览/下载:36/0  |  提交时间:2019/11/19
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis 期刊论文
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 卷号: 4, 期号: 5
作者:  Li, Jie;  Zou, Biyao;  Yeo, Yee Hui;  Feng, Yuemin;  Xie, Xiaoyu
收藏  |  浏览/下载:31/0  |  提交时间:2019/12/05
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced Non-Small Cell Lung Cancer: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
Journal of Thoracic Oncology, 2019
作者:  Yi-Long Wu;  Shun Lu;  Ying Cheng;  Caicun Zhou;  Jie Wang
收藏  |  浏览/下载:15/0  |  提交时间:2019/02/25
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis 期刊论文
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 卷号: 4, 期号: 5, 页码: 389-398
作者:  Li, Jie;  Zou, Biyao;  Yeo, Yee Hui;  Feng, Yuemin;  Xie, Xiaoyu
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/11
Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy 期刊论文
2019, 卷号: 17, 期号: 1, 页码: 339
作者:  Han Xiaohong;  Han Ying;  Tan Qiaoyun;  Huang Yu;  Yang Jianliang
收藏  |  浏览/下载:18/0  |  提交时间:2020/01/03
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer 期刊论文
2019
作者:  Xing Puyuan;  Han Xiaohong;  Wang Sha;  Liu Yutao;  Yang Sheng
收藏  |  浏览/下载:21/0  |  提交时间:2020/01/03
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China 期刊论文
2019, 卷号: 9, 期号: 5, 页码: e028589
作者:  Jiang, Shiyu;  Liu, Peng;  Yang, Sheng;  Yang, Jianliang;  Wu, Dawei
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace